A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
一项针对难治性转移性结直肠癌患者的瑞戈非尼联合PF-03446962的Ib期研究(REGAL-1试验)
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-019-03916-0
Clarke, Jeffrey Melson; Blobe, Gerard C; Strickler, John H; Uronis, Hope Elizabeth; Zafar, S Yousuf; Morse, Michael; Dropkin, Evan; Howard, Leigh; O'Neill, Margot; Rushing, Christel N; Niedzwiecki, Donna; Watson, Hollie; Bolch, Emily; Arrowood, Christy; Liu, Yingmiao; Nixon, Andrew B; Hurwitz, Herbert I